Machine Learning

With a novel 'NewCo' model and key partnerships, Banyan BioInnovations aims to de-risk and accelerate clinical-stage drugs past the funding valley of death.

A new report reveals a dramatic shift in Alzheimer's drug development, with 75% of trials now targeting pathways beyond amyloid for a new age of treatment.

A new wave of AI builds entire enterprise apps, but can it be trusted? WaveMaker's early success suggests its architecture-first approach is the key.

A new partnership moves AI from isolated tasks to integrated workflows, promising to solve the ROI problem that has plagued enterprise adoption.

Beijing has placed AI-powered robots at the core of its national strategy, aiming to reshape global manufacturing and accelerate a new technological race.

NImmune Biopharma's oral drug NIM-1324 shows promising safety and efficacy, targeting a novel pathway to treat IBD and a host of other diseases.

A new national agreement brings QuVa Pharma's AI-powered drug diversion software to thousands of hospitals, promising a high-tech solution to a hidden crisis.

A new blood test could tell you if GLP-1 drugs will work for you before you start, a major leap for precision medicine in the booming obesity market.

A biotech firm is making waves with a non-viral, redosable gene delivery system showing promise for DMD and hemophilia, challenging the industry's reliance on viruses.

With a star-studded new advisory board, Pilatus Biosciences accelerates its attack on cancer's metabolic defenses with its lead drug, PLT012.

Sensei Biotherapeutics begins a key trial for PIKTOR, a novel oral therapy aiming to outsmart cancer resistance in patients with advanced breast cancer.

Minerva Neurosciences launches a pivotal Phase 3 trial for roluperidone, a potential first-in-class drug for the untreated negative symptoms of schizophrenia.

Commvault showcases its unified, AI-enabled platform at Red Hat Summit, aiming to secure hybrid cloud workloads in a booming container market.

HealthVerity's acquisition of Symphony Health unites clinical and commercial data, promising to shatter industry silos and accelerate medical breakthroughs.

New research reveals AI is not just hype for manufacturers. Early adopters see real value in months, leaving hesitant competitors far behind.

Innovative Dining Group used AI to capture 5,100+ missed calls and book 1,200+ tables, showcasing how automation is now a key ingredient for profit.

A new partnership aims to end the 'black box' era of crypto market making, forcing a shift from reputation to verifiable, data-driven performance.

HURST Jaws of Life and Elevat launch Captium IQ, an AI-powered system designed to ensure mission-critical rescue equipment is always ready for action.

With its 100th study launch and a perfect client retention rate, Atreo's agile RTSM platform is challenging the rigid, slow pace of traditional trial tech.

With new strategic financing and powerhouse board appointments, 4D Path is accelerating its novel AI platform that predicts cancer treatment success from a single slide.